Literature DB >> 7514960

Selenium in the maintenance and therapy of HIV-infected patients.

G N Schrauzer1, J Sacher.   

Abstract

Due to its antiviral effects and its importance for all immunological functions, the administration of selenium is suggested as a supportive measure in early as well as in advanced stages of HIV-induced disease. Initial observations on the effects of selenium supplementation in HIV-infected patients indicate that selenium causes symptomatic improvements and possibly slows the course of the disease. As selenium inhibits reverse transcriptase activity in RNA-virus-infected animals, supplemental selenium could also prevent the replication of HIV and retard the development of AIDS in newly HIV-infected subjects. An adequate supply of selenium and of antioxidant vitamins is also proposed as a measure to reduce the probability of the placental transmission of HIV in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514960     DOI: 10.1016/0009-2797(94)90040-x

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

Review 1.  Nutrition and HIV infection in children.

Authors:  E E Mannick; J N Udall; M Kaiser; G Fuchs; R Suskind
Journal:  Indian J Pediatr       Date:  1996 Sep-Oct       Impact factor: 1.967

Review 2.  Selenium and cellular immunity. Evidence that selenoproteins may be encoded in the +1 reading frame overlapping the human CD4, CD8, and HLA-DR genes.

Authors:  E W Taylor
Journal:  Biol Trace Elem Res       Date:  1995 Aug-Sep       Impact factor: 3.738

3.  Antiviral Effect of Selenomethionine on Porcine Deltacoronavirus in Pig Kidney Epithelial Cells.

Authors:  Zhihua Ren; Guilin Jia; Hongyi He; Ting Ding; Yueru Yu; ZhiCai Zuo; Yanchun Hu; Zhijun Zhong; Shumin Yu; Huidan Deng; Liuhong Shen; Suizhong Cao; Guangneng Peng; Ya Wang; Dongjie Cai; Liping Gou; Xiaoping Ma; Haifeng Liu; Ziyao Zhou; Youtian Deng; Dingyong Yang; Junliang Deng
Journal:  Front Microbiol       Date:  2022-02-15       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.